VTv: Study Result Shows TTP399 Lowers Blood Glucose Without Increasing Risk Of Diabetic Ketoacidosis

Published Oct 12 2021 at 12:29 PM GMT
  • (VTVT) announced positive results of a mechanistic study of TTP399 in patients with type 1 diabetes or T1D.
  • The study demonstrated that patients with T1D taking TTP399 experienced no increase in ketone levels relative to placebo during a period of acute insulin withdrawal, indicating no increased risk of.



  • Published Oct 12, 2021 12:29 PM GMT